Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT06219720
Eligibility Criteria:
Inclusion Criteria:
* People taking 5 or more medications, including over the counter drugs, supplements, natural products, cannabis produces, or other recreational drugs
* Ability to give and comprehend the consent process.
* Consent to donate urine samples, genetic data through buccal swabs, undergo a comprehensive history and physical examination.
* All genders.
* Age 45 and over
Exclusion Criteria:
* Subject has been diagnosed or is being treated for any cancer other than basal cell cancer in the last 5 years. Patients with metastatic melanoma in the last 5 years will be excluded.
* Admitted to hospice.
* Patient has ever been diagnosed with Hepatitis B or C.
* Patient has ever been diagnosed with active liver disease, hepatomegaly, grossly abnormal liver function. Meld score \>10, ALT or AST \>100U/L or an AST/ALT ratio \>2
* Patients taking imidazole antifungal medication.
* Declines to participate or interact with staff/share their medical status.
* A diagnosis of Alzheimer's disease
* Pregnant patients will be excluded
* Unable/unwilling to consent.
* Unable to verbally communicate and comprehend English/Spanish language.
Sex:
ALL
Minimum Age:
45 Years
Study:
NCT06219720
Study Brief:
Protocol Section:
NCT06219720